Effects of Subantimicrobial-Dose Doxycycline in the Treatment of Moderate Acne
Top Cited Papers
Open Access
- 1 April 2003
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 139 (4) , 459-464
- https://doi.org/10.1001/archderm.139.4.459
Abstract
Research from JAMA Dermatology — Effects of Subantimicrobial-Dose Doxycycline in the Treatment of Moderate AcneKeywords
This publication has 9 references indexed in Scilit:
- Non‐antimicrobial and Antimicrobial Tetracyclines Inhibit IL‐6 Expression in Murine OsteoblastsAnnals of the New York Academy of Sciences, 1999
- Tetracycline derivative CMT-3 inhibits cytokine production, degranulation, and proliferation in cultured mouse and human mast cells.Annals of the New York Academy of Sciences, 1999
- Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial MechanismsAdvances in Dental Research, 1998
- Systemic Antibiotics for AcneDermatology, 1998
- A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitisInflammation Research, 1997
- Phototoxic eruptions due to doxycycline-a dose-related phenomenonClinical and Experimental Dermatology, 1993
- Low‐dose doxycycline therapy: Effect on gingival and crevicular fluid collagenase activity in humansJournal of Periodontal Research, 1990
- A Non-antibacterial Chemically-modified Tetracycline Inhibits Mammalian Collagenase ActivityJournal of Dental Research, 1987
- Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycinAntimicrobial Agents and Chemotherapy, 1982